Pharmaceutical formulations of a HIF hydroxylase inhibitor
US10765672B2 · kind B2 · utility
1Cited by
38References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2018 |
| Grant date | Sep 8, 2020 |
| Priority date | — |
| Expiry date | Jul 13, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/4825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to pharmaceutical formulations of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.